ADVANCE POC I Benefit-Risk pillar – testing new approaches to monitoring benefit/risk with pertussis vaccines as test case: benefit-risk analysis of pertussis vaccines in pre-school children comparing whole-cell and acellular formulations in the post-marketing setting

06/07/2016
02/07/2024
EU PAS number:
EUPAS13978
Study
Finalised
Documents
Study protocol
Initial protocol
English (1.38 MB - PDF) View document
Study results
Study results
English (1.07 MB - PDF) View document
English (1.79 MB - PDF) View document
Study report
Other information